These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12464646)

  • 21. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
    Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
    Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V; Handrick R; Belka C
    FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
    Shishodia S; Aggarwal BB
    Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
    Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New agents for cancer prevention.
    DuBois RN
    J Natl Cancer Inst; 2002 Dec; 94(23):1732-3. PubMed ID: 12464639
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
    Won YK; Ong CN; Shi X; Shen HM
    Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
    Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
    Schroeder CP; Kadara H; Lotan D; Woo JK; Lee HY; Hong WK; Lotan R
    Cancer Res; 2006 Oct; 66(19):9762-70. PubMed ID: 17018636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment.
    Swamy MV; Cooma I; Patlolla JM; Simi B; Reddy BS; Rao CV
    Mol Cancer Ther; 2004 Feb; 3(2):215-21. PubMed ID: 14985462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway.
    Lin MT; Lee RC; Yang PC; Ho FM; Kuo ML
    J Biol Chem; 2001 Dec; 276(52):48997-9002. PubMed ID: 11585835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation.
    Baatar D; Jones MK; Pai R; Kawanaka H; Szabo IL; Moon WS; Kitano S; Tarnawski AS
    Am J Pathol; 2002 Mar; 160(3):963-72. PubMed ID: 11891194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
    Kucab JE; Lee C; Chen CS; Zhu J; Gilks CB; Cheang M; Huntsman D; Yorida E; Emerman J; Pollak M; Dunn SE
    Breast Cancer Res; 2005; 7(5):R796-807. PubMed ID: 16168126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.